Ascic; Erhad
Patent Applications and Registrations
Patent applications and USPTO patent grants for Ascic; Erhad.The latest application filed is for "new catecholamine prodrugs for use in the treatment of parkinson's disease".
- Ascic; Erhad - Valby DK
| Patent | Date |
|---|---|
| New Catecholamine Prodrugs For Use In The Treatment Of Parkinson's Disease App 20220220077 - Jorgensen; Morten ; et al. | 2022-07-14 |
| Catecholamine Carbamate Prodrugs For Use In The Treatment Of Parkinson's Disease App 20220213040 - Jorgensen; Morten ; et al. | 2022-07-07 |
| Prodrugs Of Modulators Of The Nmda Receptor App 20220213117 - Kilburn; John Paul ; et al. | 2022-07-07 |
| Prodrugs of modulators of the NMDA receptor Grant 11,358,971 - Kilburn , et al. June 14, 2 | 2022-06-14 |
| Prodrugs Of Modulators Of The Nmda Receptor App 20210047342 - Kilburn; John Paul ; et al. | 2021-02-18 |
| Modulators Of The Nmda Receptor App 20210002292 - Kilburn; John Paul ; et al. | 2021-01-07 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 